213 related articles for article (PubMed ID: 28729456)
1. Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.
Ayyar VS; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):45-57. PubMed ID: 28729456
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.
Sukumaran S; Jusko WJ; DuBois DC; Almon RR
J Pharmacol Exp Ther; 2011 Jun; 337(3):734-46. PubMed ID: 21398515
[TBL] [Abstract][Full Text] [Related]
3. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.
Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):643-67. PubMed ID: 17593325
[TBL] [Abstract][Full Text] [Related]
4. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1998 Jun; 26(3):289-317. PubMed ID: 10098101
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
J Pharmacokinet Biopharm; 1998 Dec; 26(6):619-48. PubMed ID: 10485078
[TBL] [Abstract][Full Text] [Related]
6. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.
Hazra A; Pyszczynski NA; DuBois DC; Almon RR; Jusko WJ
Pharm Res; 2008 Apr; 25(4):769-80. PubMed ID: 17674160
[TBL] [Abstract][Full Text] [Related]
7. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.
Xu ZX; Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1995 Apr; 23(2):163-81. PubMed ID: 8719235
[TBL] [Abstract][Full Text] [Related]
8. Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.
Ayyar VS; Sukumaran S; DuBois DC; Almon RR; Qu J; Jusko WJ
J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):557-575. PubMed ID: 29704219
[TBL] [Abstract][Full Text] [Related]
9. Meta-modeling of methylprednisolone effects on glucose regulation in rats.
Fang J; Sukumaran S; Dubois DC; Almon RR; Jusko WJ
PLoS One; 2013; 8(12):e81679. PubMed ID: 24312573
[TBL] [Abstract][Full Text] [Related]
10. Quantitative tissue-specific dynamics of in vivo GILZ mRNA expression and regulation by endogenous and exogenous glucocorticoids.
Ayyar VS; Almon RR; Jusko WJ; DuBois DC
Physiol Rep; 2015 Jun; 3(6):. PubMed ID: 26056061
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper.
Lim W; Park C; Shim MK; Lee YH; Lee YM; Lee Y
Br J Pharmacol; 2014 Feb; 171(3):735-45. PubMed ID: 24172143
[TBL] [Abstract][Full Text] [Related]
12. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain.
van der Laan S; Sarabdjitsingh RA; Van Batenburg MF; Lachize SB; Li H; Dijkmans TF; Vreugdenhil E; de Kloet ER; Meijer OC
J Neurochem; 2008 Sep; 106(6):2515-23. PubMed ID: 18643788
[TBL] [Abstract][Full Text] [Related]
13. Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling.
Hazra A; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):333-54. PubMed ID: 17285360
[TBL] [Abstract][Full Text] [Related]
14. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor.
Chen W; Rogatsky I; Garabedian MJ
Mol Endocrinol; 2006 Mar; 20(3):560-72. PubMed ID: 16239257
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism.
Sun YN; McKay LI; DuBois DC; Jusko WJ; Almon RR
J Pharmacol Exp Ther; 1999 Feb; 288(2):720-8. PubMed ID: 9918581
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced leucine zipper (GILZ) is involved in glucocorticoid-induced and mineralocorticoid-induced leptin production by osteoarthritis synovial fibroblasts.
Malaise O; Relic B; Charlier E; Zeddou M; Neuville S; Deroyer C; Gillet P; Louis E; Malaise MG; de Seny D
Arthritis Res Ther; 2016 Oct; 18(1):219. PubMed ID: 27716396
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids.
Holmes MC; French KL; Seckl JR
J Neurosci; 1997 Jun; 17(11):4056-65. PubMed ID: 9151722
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression.
Yang N; Zhang W; Shi XM
J Cell Biochem; 2008 Apr; 103(6):1760-71. PubMed ID: 17910039
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver.
DuBois DC; Sukumaran S; Jusko WJ; Almon RR
Steroids; 2013 Feb; 78(2):312-20. PubMed ID: 23257260
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.
Yao Z; DuBois DC; Almon RR; Jusko WJ
J Pharm Sci; 2008 Jul; 97(7):2820-32. PubMed ID: 17828751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
